- SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD
-
Septisetyani EP, Prasetyaningrum PW, Anam K, Santoso A
- KMID: 2523800
- Immune Netw.
- 2021 Dec;21(6):e39.
- doi: 10.4110/in.2021.21.e39
The high virulent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that emerged in China at the end of 2019 has generated novel coronavirus disease, coronavirus disease 2019 (COVID-19), causing... -
- CITED
-
- Close
- SHARE
-
- Close
